Cargando…
Cambios en el manejo ambulatorio de pacientes con cáncer de próstata durante la pandemia por SARS-CoV-2. Revisión bibliográfica y aporte de nuestro grupo en atención telemática
INTRODUCTION AND OBJECTIVE: The COVID-19 pandemic has brought about changes in the management of urology patients, especially those with prostate cancer. The aim of this work is to show the changes in the ambulatory care practices by individualized telematic care for each patient profile. MATERIALS...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AEU. Published by Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084619/ https://www.ncbi.nlm.nih.gov/pubmed/34127282 http://dx.doi.org/10.1016/j.acuro.2021.04.003 |
_version_ | 1783686190181908480 |
---|---|
author | García Rodríguez, J. González Ruiz de León, C. Sacristán González, R. Méndez Ramírez, S. Modrego Ulecia, L. Fernández-Gómez, J.M. |
author_facet | García Rodríguez, J. González Ruiz de León, C. Sacristán González, R. Méndez Ramírez, S. Modrego Ulecia, L. Fernández-Gómez, J.M. |
author_sort | García Rodríguez, J. |
collection | PubMed |
description | INTRODUCTION AND OBJECTIVE: The COVID-19 pandemic has brought about changes in the management of urology patients, especially those with prostate cancer. The aim of this work is to show the changes in the ambulatory care practices by individualized telematic care for each patient profile. MATERIALS AND METHODS: Articles published from March 2020 to January 2021 were reviewed. We selected those that provided the highest levels of evidence regarding risk in different aspects: screening, diagnosis, treatment and follow-up of prostate cancer. RESULTS: We developed a classification system based on priorities, at different stages of the disease (screening, diagnosis, treatment and follow-up) to which the type of care given, in-person or telephone visits, was adapted. We established 4 options, as follows: in priority A or low, care will be given by telephone in all cases; in priority B or intermediate, if patients are considered subsidiary of an in-person visit after telephone consultation, they will be scheduled within 3 months; in priority C or high, patients will be seen in person within a margin from 1 to 3 months and in priority D or very high, patients must always be seen in person within a margin of up to 48 hours and considered very preferential. CONCLUSIONS: Telematic care in prostate cancer offers an opportunity to develop new performance and follow-up protocols, which should be thoroughly analyzed in future studies, in order to create a safe environment and guarantee oncologic outcomes for patients. |
format | Online Article Text |
id | pubmed-8084619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AEU. Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80846192021-05-03 Cambios en el manejo ambulatorio de pacientes con cáncer de próstata durante la pandemia por SARS-CoV-2. Revisión bibliográfica y aporte de nuestro grupo en atención telemática García Rodríguez, J. González Ruiz de León, C. Sacristán González, R. Méndez Ramírez, S. Modrego Ulecia, L. Fernández-Gómez, J.M. Actas Urol Esp Artículo De Revisión INTRODUCTION AND OBJECTIVE: The COVID-19 pandemic has brought about changes in the management of urology patients, especially those with prostate cancer. The aim of this work is to show the changes in the ambulatory care practices by individualized telematic care for each patient profile. MATERIALS AND METHODS: Articles published from March 2020 to January 2021 were reviewed. We selected those that provided the highest levels of evidence regarding risk in different aspects: screening, diagnosis, treatment and follow-up of prostate cancer. RESULTS: We developed a classification system based on priorities, at different stages of the disease (screening, diagnosis, treatment and follow-up) to which the type of care given, in-person or telephone visits, was adapted. We established 4 options, as follows: in priority A or low, care will be given by telephone in all cases; in priority B or intermediate, if patients are considered subsidiary of an in-person visit after telephone consultation, they will be scheduled within 3 months; in priority C or high, patients will be seen in person within a margin from 1 to 3 months and in priority D or very high, patients must always be seen in person within a margin of up to 48 hours and considered very preferential. CONCLUSIONS: Telematic care in prostate cancer offers an opportunity to develop new performance and follow-up protocols, which should be thoroughly analyzed in future studies, in order to create a safe environment and guarantee oncologic outcomes for patients. AEU. Published by Elsevier España, S.L.U. 2021-10 2021-04-30 /pmc/articles/PMC8084619/ /pubmed/34127282 http://dx.doi.org/10.1016/j.acuro.2021.04.003 Text en © 2021 AEU. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Artículo De Revisión García Rodríguez, J. González Ruiz de León, C. Sacristán González, R. Méndez Ramírez, S. Modrego Ulecia, L. Fernández-Gómez, J.M. Cambios en el manejo ambulatorio de pacientes con cáncer de próstata durante la pandemia por SARS-CoV-2. Revisión bibliográfica y aporte de nuestro grupo en atención telemática |
title | Cambios en el manejo ambulatorio de pacientes con cáncer de próstata durante la pandemia por SARS-CoV-2. Revisión bibliográfica y aporte de nuestro grupo en atención telemática |
title_full | Cambios en el manejo ambulatorio de pacientes con cáncer de próstata durante la pandemia por SARS-CoV-2. Revisión bibliográfica y aporte de nuestro grupo en atención telemática |
title_fullStr | Cambios en el manejo ambulatorio de pacientes con cáncer de próstata durante la pandemia por SARS-CoV-2. Revisión bibliográfica y aporte de nuestro grupo en atención telemática |
title_full_unstemmed | Cambios en el manejo ambulatorio de pacientes con cáncer de próstata durante la pandemia por SARS-CoV-2. Revisión bibliográfica y aporte de nuestro grupo en atención telemática |
title_short | Cambios en el manejo ambulatorio de pacientes con cáncer de próstata durante la pandemia por SARS-CoV-2. Revisión bibliográfica y aporte de nuestro grupo en atención telemática |
title_sort | cambios en el manejo ambulatorio de pacientes con cáncer de próstata durante la pandemia por sars-cov-2. revisión bibliográfica y aporte de nuestro grupo en atención telemática |
topic | Artículo De Revisión |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084619/ https://www.ncbi.nlm.nih.gov/pubmed/34127282 http://dx.doi.org/10.1016/j.acuro.2021.04.003 |
work_keys_str_mv | AT garciarodriguezj cambiosenelmanejoambulatoriodepacientesconcancerdeprostatadurantelapandemiaporsarscov2revisionbibliograficayaportedenuestrogrupoenatenciontelematica AT gonzalezruizdeleonc cambiosenelmanejoambulatoriodepacientesconcancerdeprostatadurantelapandemiaporsarscov2revisionbibliograficayaportedenuestrogrupoenatenciontelematica AT sacristangonzalezr cambiosenelmanejoambulatoriodepacientesconcancerdeprostatadurantelapandemiaporsarscov2revisionbibliograficayaportedenuestrogrupoenatenciontelematica AT mendezramirezs cambiosenelmanejoambulatoriodepacientesconcancerdeprostatadurantelapandemiaporsarscov2revisionbibliograficayaportedenuestrogrupoenatenciontelematica AT modregoulecial cambiosenelmanejoambulatoriodepacientesconcancerdeprostatadurantelapandemiaporsarscov2revisionbibliograficayaportedenuestrogrupoenatenciontelematica AT fernandezgomezjm cambiosenelmanejoambulatoriodepacientesconcancerdeprostatadurantelapandemiaporsarscov2revisionbibliograficayaportedenuestrogrupoenatenciontelematica |